In the presence of a JNK inhibitor (SP600125), caspase 3/7 activation and sensitization to RT-induced cell death were completely mitigated in L3.6pl (Figure 6A,C) and Panc1 (Figure 6B,D) pancreatic cancer cells. This evidence concerns the gene CASP3 and familial pancreatic carcinoma.